Free to read · nothing for sale · no ads, no sponsors · funded by donation

Open Source Apothecary At Home

Open Source Apothecary At Home / Digestion

Liver and bile: milk thistle, artichoke, and the limits of liver herbs

There is no herb that treats liver disease, and one poison that must never be taken again.

remedy

Milk thistle is the most studied liver herb and the honest summary is disappointing: silymarin has a plausible antioxidant and antifibrotic mechanism, and trials in chronic liver disease have mostly failed to show a clear clinical benefit. A systematic review finding no consistent effect is a finding, and it should be reported as plainly as a positive one would be. Milk thistle is safe and well tolerated; it is not a treatment for cirrhosis or hepatitis.

What genuinely works for the liver. Stopping the insult: alcohol, the offending drug, the metabolic syndrome driving fatty liver. Weight loss and glycaemic control have the best evidence for non-alcoholic fatty liver disease, which is the common form and which is a metabolic disease rather than a toxin story. Vaccination for hepatitis A and B where indicated. Treating the underlying viral hepatitis with antiviral therapy, which is a medical decision with a cure rate.

Acetaminophen (paracetamol) overdose is the one liver emergency with a specific antidote, and it is N-acetylcysteine given as early as possible. This is not a herbal matter and there is no home equivalent. An overdose can feel fine for a day while the liver is being destroyed; the antidote is most effective in the first 8 hours and still useful later. If any doubt exists about the amount taken, go to an emergency department immediately and take the packet.

Bitters and bile. Artichoke leaf stimulates bile flow and has trials in dyspepsia. It is contraindicated where a gallstone is obstructing the bile duct, because increasing flow into an obstruction causes pain. Gallstones that are causing pain are a surgical conversation.

What to be careful of. Herbal liver injury is a real category covered on its own page: kava, greater celandine, germander, comfrey and other pyrrolizidine plants, Aristolochia, and multi-herb Chinese formulas. A person with a liver condition should treat every supplement as a drug to be discussed.

What the studies found

Meta-Analysis2024ANZ journal of surgery

Systematic review and meta-analysis of the effect of N-acetylcysteine on outcomes after liver resection.

The administration of NAC in liver resection did not alter important biochemical parameters suggesting any real effectiveness in reducing hepatic dysfunction.
PubMed 39101362 ↗
Meta-Analysis2020Expert review of clinical pharmacology

Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis.

N-acetyl cysteine, but not Silymarin/Silibinin, appears to be beneficial in prevention of ATT-DILI.
PubMed 33043729 ↗
Meta-Analysis2020The Cochrane database of systematic reviews

N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.

The available evidence is inconclusive regarding the effect of N-acetylcysteine compared with placebo or no N-acetylcysteine, as an adjunct to usual care, on mortality or transplant rate in non-paracetamol-induced acute liver failure.
PubMed 33294991 ↗
Meta-Analysis2016Advanced emergency nursing journal

N-Acetylcysteine Use in Non-Acetaminophen-Induced Acute Liver Failure.

Liver transplantation remains the only definitive therapy in advanced disease.
PubMed 27482990 ↗
Systematic Review2025British journal of clinical pharmacology

Epigenetic modifications in drug-induced liver injury: A systematic review.

Genetic susceptibility has been identified in idiosyncratic drug-induced liver injury, a potentially severe adverse reaction towards drugs, herbal products and dietary supplements.
PubMed 40441699 ↗
Systematic Review2025British journal of clinical pharmacology

Epigenetic modifications in drug-induced liver injury: A systematic review.

Genetic susceptibility has been identified in idiosyncratic drug-induced liver injury, a potentially severe adverse reaction towards drugs, herbal products and dietary supplements.
PubMed 40134104 ↗

Preparation

Milk thistle

  • 1-2 g crushed seed per cup, or a standardised extract stated as silymarin content
  • Seed must be crushed; the whole seed passes through
  • Trials have used 140-800 mg silymarin daily; a household tea is far below that
  • Safe and well tolerated; not a treatment for liver disease

Artichoke leaf as a bitter

  • 1-2 g dried leaf as a tea, or a standardised extract
  • 15-30 minutes before a meal, so the bitter taste registers
  • Do not use with gallstones or bile duct obstruction

Nettle and dandelion root

  • Traditional "liver" teas. Neither has trial evidence of clinical benefit in liver disease; both are harmless in food amounts.

The interventions that do work

  • Complete alcohol abstinence in any liver disease
  • Stop the offending drug with medical advice
  • Weight loss of 7-10% for fatty liver disease, which has the trial evidence
  • Hepatitis A and B vaccination; hepatitis B and C antiviral treatment where indicated
  • N-acetylcysteine for paracetamol overdose, in hospital, as early as possible

Cautions and interactions

When this is not a self-care problem — get help

Related

Sources

  1. Systematic review and meta-analysis of the effect of N-acetylcysteine on outcomes after liver resection. ANZ journal of surgery 2024; doi:10.1111/ans.19183 PubMed 39101362
  2. Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis. Expert review of clinical pharmacology 2020; doi:10.1080/17512433.2020.1835468 PubMed 33043729
  3. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure. The Cochrane database of systematic reviews 2020; doi:10.1002/14651858.CD012123 PubMed 33294991
  4. N-Acetylcysteine Use in Non-Acetaminophen-Induced Acute Liver Failure. Advanced emergency nursing journal 2016; doi:10.1097/TME.0000000000000116 PubMed 27482990
  5. Epigenetic modifications in drug-induced liver injury: A systematic review. British journal of clinical pharmacology 2025; doi:10.1111/bcp.70053 PubMed 40441699
  6. Epigenetic modifications in drug-induced liver injury: A systematic review. British journal of clinical pharmacology 2025; doi:10.1002/bcp.70053 PubMed 40134104